A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation
Tomography · 2023
DOI: 10.3390/tomography9050149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tomography, 2023. Verfasst von Stephane Chauvie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics Division, Santa Croce e Carle Hospital, 12100 Cuneo, Italy. Hauptthemen laut MEDLINE: Diagnostic Imaging. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Imaging biomarkers (IBs) have been proposed in medical literature that exploit images in a quantitative way, going beyond the visual assessment by an imaging physician. These IBs can be used in the diagnosis, prognosis, and response assessment of several pathologies and are very often used for patient management pathways. In this respect, IBs to be used in clinical practice and clinical trials have a requirement to be precise, accurate, and reproducible. Due to limitations in imaging technology, an error can be associated with their value when considering the entire imaging chain, from data acquisition to data reconstruction and subsequent analysis. From this point of view, the use of IBs in clinical trials requires a broadening of the concept of quality assurance and this can be a challenge for the responsible medical physics experts (MPEs). Within this manuscript, we describe the concept of an IB, examine some examples of IBs currently employed in clinical practice/clinical trials and analyze the procedure that should be carried out to achieve better accuracy and reproducibility in their use. We anticipate that this narrative review, written by the components of the EFOMP working group on “the role of the MPEs in clinical trials”-imaging sub-group, can represent a valid reference material for MPEs approaching the subject.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Physics Division, Santa Croce e Carle Hospital, 12100 Cuneo, Italy.
- Medical Physics Unit, AUSL Toscana Centro, 51100 Pistoia, Italy.
- Siemens Medical Solutions, Malvern, PA 19355, USA.
- Department of Radiology & Radiological Sciences, Medical University of South Carolina, Charleston, SC 20455, USA.
- Radiography & Diagnostic Imaging, University College Dublin, D04 C7X2 Dublin, Ireland.
ORCID-Profile: Stephane Chauvie, Lorenzo Nicola Mazzoni, Jim O'Doherty
Zitieren
APA
Chauvie, S., Mazzoni, L. N., & O'Doherty, J. (2023). A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation. Tomography. https://doi.org/10.3390/tomography9050149
Vancouver
Chauvie S, Mazzoni LN, O'Doherty J. A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation. Tomography. 2023. doi:10.3390/tomography9050149
BibTeX
@article{Chauvie2023,
author = {Chauvie, Stephane and Mazzoni, Lorenzo Nicola and O'Doherty, Jim},
title = {A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation},
journal = {Tomography},
year = {2023},
doi = {10.3390/tomography9050149}
}
EUVIMED